AHN Cancer Institute - Allegheny General — Pittsburgh, Pennsylvania

AHN Cancer Institute - Allegheny General is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

AHN Cancer Institute - Allegheny General has participated in 1 clinical trials.

Therapeutic areas: Chemoradiotherapy-Induced Severe Oral Mucositis.

Sponsors: Monopar Therapeutics.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AHN Cancer Institute - Allegheny General?

AHN Cancer Institute - Allegheny General has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AHN Cancer Institute - Allegheny General conducted?

AHN Cancer Institute - Allegheny General has 1 clinical trials on record. Their work covers Chemoradiotherapy-Induced Severe Oral Mucositis.

Is AHN Cancer Institute - Allegheny General accredited by Crixeo Health?

AHN Cancer Institute - Allegheny General has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AHN Cancer Institute - Allegheny General?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.